Reactive Oxygen Species and the Central Nervous System

Journal of Neurochemistry

Volumn 59, Issue 5, 1992, Pages 1609-1623

  Halliwell, Barry ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antioxidant enzyme; Chelator; Hydrogen peroxide; Oxidative stress; Parkinson's disease; Radical; Superoxide

Indexed keywords

CALCIUM; COPPER ION; FERRIC ION; HYDROGEN PEROXIDE; NITRIC OXIDE; OXYGEN RADICAL; SUPEROXIDE;

ALZHEIMER DISEASE; BRAIN METABOLISM; CALCIUM CELL LEVEL; HUMAN; ION TRANSPORT; IRON CHELATION; NEUROTOXICITY; OXIDATION; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SECRETION; SHORT SURVEY; TISSUE INJURY;

ANIMAL; CENTRAL NERVOUS SYSTEM; FREE RADICALS; HUMAN; REACTIVE OXYGEN SPECIES;

EID: 0026754574     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.1992.tb10990.x     Document Type: Article

References (182)

1. Aluminum uptake and toxicity in cultured mouse hepatocytes
2. Biochemical mechanisms of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine toxicity. Could oxidative stress be involved in the brain
3. Free radical production and ischemic brain damage: influence of post‐ischemic oxygen tension
4. Reducing postischemic paraplegia using conjugated superoxide dismutase
5. Parkinsons disease: pathophysiology
6. 3H]spiroperidol in human caudate and putamen: guanyl nucleotides enhance ascorbateinduced lipid peroxidation and cause an apparent loss of high affinity binding site
7. Manganese poisoning and the attack of trivalent manganese upon catecholamines
8. Superoxide‐dependent and ascorbate‐dependent formation of hydroxyl radicals from hydrogen peroxide in the presence of iron. Are lactoferrin and transferrin promoters of hydroxyl radical generation
9. The mechanism of initiation of lipid peroxidation. Evidence against a requirement for an iron(II)‐iron(III) complex
10. Copper ion‐dependent damage to the bases in DNA in the presence of hydrogen peroxide
11. Down's syndrome: abnormal neuromuscular junction in tongue of transgenic mice with elevated levels of human Cu/Zn‐superoxide dismutase
12. Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species
13. The double‐edged role of nitric oxide in brain function and superoxide‐mediated injury
14. Intranigral iron injection induces behavioural and biochemical “parkinsonism” in rats
15. Identification of hypoxanthine transport and xanthine oxidase activity in brain capillaries
16. Xanthine oxidase is not a major source of free radicals in focal cerebral ischemia
17. Studies of hypervalent iron. Free Radic
18. Intraarticular ferritin‐bound iron in rheumatoid arthritis. A factor that increases oxygen free radical‐induced tissue destruction
19. Aluminium, chemical physiology and Alzheimer's disease
20. Cerebral and ocular toxicity induced by desferrioxamine
21. On the limited ability of superoxide to release iron from ferritin
22. Effect of acidosis and anoxia on iron delocalization from brain homogenates
23. Novel 21‐amino steroids as potent inhibitors of iron‐dependent lipid peroxidation
24. Acidosis protects against lethal oxidative injury of liver sinusoidal endothelial cells
25. Vitamin E as an in vitro and in vivo antioxidant
26. Reversal of age‐related changes in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin trapping compound N‐tertbutyl‐α‐phenylnitrone
27. Neuronal‐specific expression of human copperzinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndrome
28. Protective effects of liposome‐entrapped superoxide dismutase on post‐traumatic brain edema
29. Reduced neurotoxicity in transgenic mice overexpressing human copper‐zinc‐superoxide dismutase
30. The role of mixed function oxidase (MFO) in the metabolism of the spin trapping agent α‐phenyl‐N‐tert‐butyl‐nitrone (PEN) in rats
31. Mechanisms of oxidant injury of cells
32. Oxygen radicals and Parkinson's disease
33. Production of superoxide anions by a CNS macrophage, the microglia
34. The action of hydrogen peroxide on paired‐pulse and long‐term potentiation in the hippocampus
35. The effect of xanthine/xanthine oxidase generated reactive oxygen species on synaptic transmission
36. Iron transport and storage
37. Chronic granulomatous disease
38. Detection of myoglobin‐derived radicals on reaction of metmyoglobin with hydrogen peroxide and other peroxidic compounds
39. Identification of a globin free radical in equine myoglobin treated with peroxides
40. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures
41. Oxygen free radicals in central nervous system ischemia and trauma
42. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease
43. Alterations in the levels of iron ferritin and other trace metals in Parkinson's disease and in other neurodegenerative diseases affecting the basal ganglia
44. Mechanism of kainate toxicity to cerebellar neurons in vitro is analogous to reperfusion tissue injury
45. Lipid peroxidation products: formation, chemical properties and biological activities
46. Continuous monitoring of in vitro oxidation of human low‐density lipoprotein
47. Non‐caeruloplasmin copper and ferroxidase activity in mammalian serum. Ferroxidase activity and phenanthroline‐detectable copper in human serum in Wilsons disease
48. Oxidative damage to behavior during aging
49. Isoforms of nitric oxide synthase
50. + and analogs. Evidence against a “redox cycling” mechanism in MPTP neurotoxicity
51. Ascorbate is an outstanding antioxidant in human blood plasma
52. The biology of oxygen radicals
53. Superoxide dismutases. An adaptation to a paramagnetic gas
54. Superoxide sensitivity of the Escherichia coli 6‐phosphogluconate dehydratase
55. Superoxide sensitivity of the Escherichia coli aconitase
56. Oxygen poisoning and x‐irradiation: a mechanism in common
57. Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study
58. Down syndrome clinical symptoms are manifested in transfected cells and transgenic mice overexpressing the human Cu/Zn‐superoxide dismutase gene
59. Iron, transferrin and ferritin in cerebrospinal fluid of children
60. Copper‐phenanthroline induced site‐specific oxygen radical damage to DNA
61. Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides
62. The antioxidant activity of haptoglobin towards haemoglobin‐stimulated lipid peroxidation
63. Brain iron and oxygen radicals
64. Radical‐promoting loosely‐bound iron in biological fluids and the bleomycin assay
65. Antioxidant protection by haemopexin of haem‐stimulated lipid peroxidation
66. Caeruloplasmin: physiological and pathological perspectives
67. Aluminium salts accelerate peroxidation of membrane lipids stimulated by iron salts
68. Effects of the 21‐aminosteroid U74006F on post‐traumatic spinal cord ischemia in cats
69. The role of oxygen radical‐induced lipid peroxidation in acute central nervous system trauma
70. Attenuation of postischemic cerebral hypoperfusion by the 21‐aminosteroid U74006F
71. Effects of the 21‐aminosteroid U74006F on experimental head injury in mice
72. Attenuation of hemorrhagic shock by the non‐glucocorticoid 21‐aminosteroid U74006F
73. Non‐steroidal lazaroid U78517F in models of focal and global ischemia
74. Manganese ions, oxidation reactions and the superoxide radical
75. Oxidants and human disease: some new concepts
76. Superoxide, iron, vascular endothelium and reperfusion injury
77. Protection against tissue damage in vivo by desferrioxamine. What is its mechanism of action
78. How to characterize a biological antioxidant
79. DNA damage by oxygen‐derived species. Its mechanism and measurement in mammalian systems
80. Lipid peroxidation, oxygen radicals, cell damage and antioxidant therapy
81. Oxygen toxicity, oxygen radicals, transition metals and disease
82. Oxygen radicals and the nervous system
83. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts
84. Role of free radicals and catalytic metal ions in human disease: an overview
85. The antioxidants of human extracellular fluids
86. Bleomycin‐detectable iron in serum from leukaemic patients before and after chemotherapy
87. Free radicals, antioxidants and human disease—where are we now
88. Quicker metabolic recovery after forebrain ischemia in rats treated with the antioxidant U74006F
89. Inhibitory effects of Ebselen on lipid peroxidation in rat liver microsomes
90. Polyethylene glycol‐conjugated superoxide dismutase fails to blunt postischemic reactive hyperemia
91. Iron and aluminium increase in the substantia nigra of patients with Parkinson's disease: an x‐ray microanalysis
92. Neuronal NADPH diaphorase is a nitric oxide synthetase
93. DNA damage and oxygen radical toxicity
94. Glutathione deficiency leads to mitochondrial damage in brain
95. Oxidative stress as a cause of Parkinson's disease
96. Initiation of lipid peroxidation in biological systems
97. Concepts related to the study of reactive oxygen and cardiac reperfusion injury
98. The myoglobin‐derived radical formed on reaction of metmyoglobin with hydrogen peroxide is not a tyrosine peroxyl radical
99. 2+ by toxic agents; an index of potential neurotoxicity
100. Aluminium (III) facilitates the oxidation of NADH by the superoxide ion
101. Endocytosis of superoxide dismutase is required in order for the enzyme to protect hepatocytes from the cytotoxicity of hydrogen peroxide
102. Neurotoxins, parkinsonism and Parkinson's disease
103. Antioxidant and pro‐oxidant actions of the plant phenolics quercetin, gossypol and myricetin. Effects on lipid peroxidation, hydroxyl radical generation and bleomycin‐dependent damage to DNA
104. Evidence for superoxide radical‐dependent coronary vasospasm after angioplasty in intact dogs
105. Oxygen radicals: common mediators of neurotoxicity
106. Effect of U74006F on forebrain ischemia in rats
107. Selective vulnerability of glutathione metabolism and cellular defense mechanisms in rat striatum to manganese
108. Prevention of reusion injury of the ischemic spinal cord: use of recombi superoxide dismutase
109. Xanthine dehydrogenase and oxidase in focal cerebral emic injury to rat
110. A review of hemoglobin the pathogenesis of cerebral vasospasm
111. The B‐lymphocyte: a newly‐recognized source of tive oxygen species with immunoregulatory potential
112. Oxygen‐derived free radicals in post‐ischemic e injury
113. Superoxide inactivates tine phosphokinase during reperfusion of ischemic heart, xyRadicals
114. Intramusr desferrioxamine in patients with Alzheimer's disease
115. Human fibroblasts release reactive gen species in response to treatment with synovial fluids n patients suffering from arthritis
116. Excitatory amino acids and anoxic/ischemic n damage
117. Genotoxicity of active oxygen species in nmalian cells
118. 2+‐mediated activation hosphoenolpyruvate carboxykinase occurs via release of from rat liver mitochondria
119. Breathing 100% oxygen after al brain ischemia in mongolian gerbils results in increased peroxidation and increased mortality
120. Nitric oxide: siology, pathophysiology and pharmacology
121. 3H)‐spiperone bind‐°Consequent to lipid peroxidation in rat cortical memaes
122. A novel biology active selenoorganic compound. I. Glutathione peroxie activity in vitro and anti‐oxidant capacity of PZ51 (Ebse)
123. Neurochemical, rophysiological and neuropathological studies in vitamin E °Ciency
124. Modula of fibroblast proliferation by oxygen free radicals
125. The role of reperfusion‐induced injury in the hogenesis of the crush syndrome
126. Interaction between free radicals excitatory amino acids in the formation of ischemic brain ma in rats
127. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion‐induced injury to gerbil brain
128. Oxidation reactions in Parkinson's disease
129. MR imaging of putamenal iron predicts response to dopaminergic therapy in Parkinsonian patients
130. 2+ in toxic cell killing
131. Raised cerebrospinalfluid copper concentrations in Parkinson's disease
132. Immunohistochemical evidence of antioxidant stress in Alzheimer's disease
133. Xanthine oxidase‐derived hydrogen peroxide contributes to ischemia reperfusion‐induced edema in gerbil brains
134. Excitatory amino acid release from rat hippocampal slices as a consequence of free‐radical formation
135. Free radicals accelerate the decay of long‐term potentiation in field CAI of guinea‐pig hippocampus
136. Pretreatment with U74006F improves neurologic outcome following complete cerebral ischemia in dogs
137. 3H]‐MPTP binding in the brains of superoxide dismutase transgenic mice
138. Formation of hydroxyl radicals from hydrogen peroxide in the presence of iron. Is haemoglobin a biological Fenton catalyst
139. Action of lead (II) and aluminium (III) ions on iron‐stimulated lipid peroxidation in liposomes, erythrocytes and rat liver microsomal fractions
140. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide
141. Association of antioxidant systems in the protection of human fibroblasts against oxygen derived free radicals
142. Transition metals, ferritin, glutathione and ascorbic acid in parkinsonian brains
143. Serum iron and neuroleptic malignant syndrome
144. Focal epileptogenesis following intracortical haemoglobin injection
145. Hemoglobin potentiates central nervous system damage
146. 21‐Aminosteroids interact with the dopamine transporter to protect against 1‐methyl‐4‐phenylpyridinium‐induced neurotoxicity
147. Oxidative mechanisms underlying methyl mercury neurotoxicity
148. −. Implications for the action of endothelium‐derived relaxing factor
149. Inactivation of mammalian brain glutamine synthetase by oxygen radicals
150. Superoxide dismutaserich bacteria: paradoxical increase in oxidant toxicity
151. 1 reductase (complex I) deficiency in Parkinson's disease
152. Mechanisms of ischemic brain damage
153. Calcium, excitotoxins and brain damage
154. Influence of acidosis on lipid peroxidation in brain tissues in vitro
155. Biochemistry of the neurotoxic action of MPTP
156. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease
157. Selective increase of iron in substantia nigra zona compacta of Parkinsonian brains
158. 2+) complex: a possible mechanism of nigrostriatal cell damage
159. Deoxynucleoside and vitamin transport into the central nervous system
160. Free radicals mediate actions of oxyhemoglobin on cerebrovascular smooth muscle cells
161. The inhibition of lipid autoxidation by human serum and its relationship to serum proteins and alpha‐tocopherol
162. Generation of superoxide anion by brain endothelial cell xanthine oxidase
163. The molecular genetics of superoxide dismutase in E. coli. An approach to understanding the biological role and regulation of SODs in relation to other elements of the defense system against oxygen toxicity
164. Oxygen radical mechanisms of brain injury following ischemia and reperfusion
165. Protection against oxygen toxicity by intravenous injection of liposomeentrapped catalase and superoxide dismutase
166. + neurotoxicity by N‐methyl‐D‐aspartate antagonists
167. Mechanisms of lipid peroxidation potentiated by ischemia in the brain
168. Iron depletion—a defense against intracellular infection and neoplasia
169. Effect of chlorpromazine on central nervous system concentrations of manganese, iron and copper
170. Dendritic alterations in rat isocortex within an iron‐induced chronic epileptic focus
171. The role of iron‐induced hippocampal peroxidation in acute epileptogenesis
172. 2O2‐reactive species in oxygen toxicity in biology
173. EPR Spin‐trapping study on the oxidizing species formed in the reaction of the ferrous ion with hydrogen peroxide
174. Iron in the brain: implications for Parkinson's and Alzheimer's diseases
175. The neurotoxic component in Parkinson's disease may involve iron‐melanin interaction and lipid peroxidation in the substantia nigra
176. Prevention of H2O2 generation by monomine oxidase protects against CNS O2 toxicity
177. The oxidative inactivation of mitochondrial electron transport chain components and ATPase